您的位置: 首页 > 农业专利 > 详情页

6-arylalkylamino- 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2c receptor agonists
专利权人:
Eli Lilly and Company
发明人:
Adeva Bartolome, Marta,Martinez-Grau, Maria Angeles,Reinhard, Matthew Robert,O'Toole, John Cunningham,Cases-Thomas, Manuel Javier,Rathmell, Richard Edmund,Williams, Andrew Caerwyn,Mazanetz, Michael Ph,OToole, John Cunningham,Mazanetz, Michael Phi
申请号:
AU2006287202
公开号:
AU2006287202B2
申请日:
2006.09.01
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
The present invention provides 6-substituted 2,3,4,5-tetrahydro-lH- benzo[d]azepinesof Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2cassociated disorders including obesity, obsessive/compulsive disorder,depression, and anxiety, where, R6 is -NR10R11, where R10 is substituted phenylalkylor substituted pyridylalkyl and other substituents are as defined in the specification.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充